From “PR Newswire”:

Relay Therapeutics, Inc. is set to present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 2:15 p.m. PT. Sanjiv Patel, M.D., President and CEO of the company, will be giving the presentation. The webcast of the presentation will be accessible through Relay Therapeutics’ website. The company is a clinical-stage precision medicine company aimed at transforming the drug discovery process through leading-edge computational and experimental technologies.

Relay Therapeutics, Inc.’s goal is to bring life-changing therapies to patients through the use of a Dynamo™ platform. This platform integrates an array of leading-edge computational and experimental approaches that are designed to drug protein targets that have been previously intractable or inadequately addressed. The company’s initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, visit www.relaytx.com. Contact for more information is Megan Goulart at 617-545-5526 or [email protected].



Read more: Relay Therapeutics to Present at 42nd Annual J.P. Morgan